2025 Drug reviews archive

2025 Oregon PDAB drug review resources

FINAL PRESCRIPTION MEDICATION LIST FOR 2025 REVIEW
2023 prescription medication subset list for 2025 review
Oregon PDAB subset list data dashboard
Public comments about medications under review
PDAB Data Dictionary (PDF)
PDAB Data Dictionary (Excel)
Subset list of prescription drugs, March 19,2025
Subset list of insulin products, April 16, 2025
Public comments about all medications
Preliminary drug list data process document
Insulin data process document
OAR-925-200-0010 - criteria for the selection of the subset list of drugs
OAR-925-200-0020 - criteria for drug reviews

Archived Drug Reviews

2025

This content is archived to conform with the rule on digital accessibility under Americans with Disabilities Act. It is retained exclusively for reference, research, or recordkeeping and is not altered or updated after the date of archiving.

This table provides links to the 2025 Oregon PDAB drug review documents, videos, minutes

Drug review document	Meeting video	Meeting minutes
Vraylar, Entresto, Ajovy, Emgality, Nurtec, Ubrelvy	July 16, 2025	July 16, 2025
Trelegy, Eliquis, Xarelto, Cosentyx, Creon	Aug. 20, 2025	Aug. 20, 2025
Jardiance, Mounjaro, Ozempic, Rybelsus, Trulicity	Sept. 17, 2025	Sept. 17, 2025
Insulin products Basaglar KwikPen, Insulin Glargine-yfgn, Lantus, Lantus SoloStar, Semglee, Toujeo Max SoloStar, Toujeo SoloStar	Oct. 15, 2025	Oct. 15, 2025